Logo for Modern Synthesis

Meet an Unreasonable Venture

Modern Synthesis

Manufacturing the next generation of biomaterials

Photo of Jennifer Keane

Jennifer Keane

CEO & Co-Founder at Modern Synthesis

More about Jennifer »
Employees 6–20
Headquarters London, England, United Kingdom
Modern Synthesis is a London-based biomaterial startup that crafts progressive biomaterials and tangible material solutions for the fashion industry. While increasingly natural and biobased alternatives to synthetic materials are becoming available, most current alternatives either fail to meet the industry demand in aesthetics, performance, and cost or still rely on the use of harsh chemicals and synthetic binders. However, Modern Synthesis’ patent-pending “microbial weaving” process is poised to overcome these historical limitations. Their proprietary process employs bacteria to grow a strong, lightweight cellulose-based composite material that is naturally biodegradable and offers unique potential for aesthetic and performance customizations. While the materials’ strength and durability are comparable to that of natural and synthetic leather, the process requires a fraction of greenhouse gases, water, and land usage.

Notable Achievements

  • Raised over $5.5M to date from Collaborative Fund, Petri Bio, Agfunder, AceCap and others
  • CEO is an award winning designer, previously working on global material initiatives at adidas
  • Modern Synthesis is working with leading global brands to help them transition away from animal and petrochemical derived materials

Press Mentions

April 4, 2023

These textiles were grown by bacteria

Read on Fast Company »

September 20, 2023

Modern Synthesis and GANNI unveil 'Bou Bag' made by bacteria

Read on AgFunderNews »

More Ventures in Energy & Environment

Get the Unreasonable Newsletter

Get monthly updates on Modern Synthesis and over 386 other ventures working to solve the world's toughest problems.

Read our Privacy Policy.